Hong Kong R&D Super-Deduction for Profits Tax: How It Works

Hong Kong R&D Super-Deduction for Profits Tax

The Hong Kong R&D super-deduction allows businesses to claim an enhanced deduction for qualifying research and development expenditure when computing assessable profits for profits tax. The relief encourages innovation by reducing the effective cost of R&D activities undertaken in Hong Kong. Depending on the expenditure type, a company may deduct 200% to 300% of the qualifying amount from its assessable profits, lowering its overall profits tax liability.

Claim the deduction through the profits tax return - Form BIR51 for corporations - and support it with supplementary forms detailing the R&D expenditure. The Inland Revenue Department (IRD) administers the scheme. The relief applies to expenditure incurred in a year of assessment on eligible R&D activities conducted in Hong Kong. The super-deduction does not replace capital allowances. The rules for capital expenditure on R&D differ from those for revenue expenditure.

Qualifying R&D Expenditure and Deduction Rates

The enhanced deduction applies to two categories of qualifying R&D expenditure: Type A and Type B.

Type A expenditure covers qualifying R&D directly undertaken by the taxpayer in Hong Kong. This includes staff costs, consumable materials, and overheads directly attributable to R&D activities. For Type A expenditure, the deduction is 200% of the qualifying amount - HK$2 deducted for every HK$1 spent.

Type B expenditure covers qualifying R&D outsourced to a third party, such as a research institute, university, or a designated R&D centre in Hong Kong. The deduction for Type B expenditure is 300% of the qualifying amount - HK$3 deducted for every HK$1 spent. This higher rate applies only to the first HK$3 million of such expenditure in a year of assessment. Any excess is treated as Type A expenditure at the 200% rate.

To qualify, the R&D must be conducted in Hong Kong and meet the definition of scientific or technological research directed at innovation, not routine or incremental improvements. The IRD looks to the definition in section 2 of the Inland Revenue Ordinance (Cap. 112), which refers to systematic, investigative or experimental activities designed to acquire new knowledge or develop new or improved products, processes, or services.

R&D Tax Deduction Hong Kong: How the Relief Reduces Assessable Profits

The r&d tax deduction hong kong works by reducing the taxpayer's assessable profits for the year of assessment in which the expenditure is incurred. Spend HK$1 million on Type A R&D, and deduct HK$2 million from assessable profits. Spend HK$1 million on Type B R&D within the HK$3 million cap, and deduct HK$3 million.

This deduction is in addition to the normal deduction for the expenditure itself. The super-deduction does not create a refundable cash loss. It increases the tax loss that can be carried forward indefinitely against future assessable profits from the same trade. Hong Kong has no group loss relief. Each company must utilise its own losses.

Claim the deduction on the profits tax return and complete the relevant supplementary form - Form S6, relating to R&D expenditure - to provide details of the qualifying activities and amounts. The IRD may request supporting documentation, including project descriptions, expenditure breakdowns, and certification from qualified professionals where applicable.

Hong Kong Research and Development Tax Incentive: Qualifying Activities

The hong Kong research and development tax incentive extends to activities that meet the definition of R&D: basic research, applied research, and experimental development undertaken to create new or improved products, processes, or services. Routine data collection, market research, quality control, and routine testing are not qualifying R&D activities.

Activities must be conducted in Hong Kong to qualify. R&D outsourced to an overseas entity does not qualify for the super-deduction, though it may still be deductible as an ordinary business expense. The IRD may scrutinise transactions with connected entities to ensure the expenditure is arm's length and not artificially inflated to claim the enhanced deduction.

Maintain contemporaneous records. Project plans, records of experiments, and financial accounts tracking expenditure. The IRD may request these during a field audit or tax investigation.

Super-Deduction Hong Kong Profits Tax: Interaction with Capital Allowances

The super-deduction hong kong profits tax does not apply to capital expenditure on R&D assets. Capital expenditure on plant, machinery, or buildings used for R&D is instead eligible for depreciation allowances under the Inland Revenue Ordinance. A company that purchases a specialised R&D machine cannot treat that cost as qualifying R&D expenditure. It must claim industrial building allowance or plant and machinery allowance instead.

The IRD has confirmed that certain expenditure on R&D that is capital in nature but not otherwise covered by depreciation allowances may still qualify for the super-deduction in specific cases. The distinction between revenue and capital expenditure is fact-sensitive. Refer to the IRD's published guidance and, where necessary, seek advance clarification before filing a return.

Where a company incurs both revenue and capital expenditure on R&D, it must separate the two in its tax computation. The IRD provides a supplementary form for the super-deduction claim that asks the taxpayer to confirm the nature of the expenditure.

Hong Kong Innovation Tax Relief: Claiming the Deduction

The hong kong innovation tax relief is claimed by completing the profits tax return - Form BIR51 for corporations - and the relevant supplementary form for R&D expenditure. The taxpayer must state the total qualifying Type A and Type B expenditure, the amounts claimed as super-deductions, and the resulting reduction in assessable profits.

The year of assessment in which the expenditure is incurred is the year for which the deduction is claimed. If the expenditure is incurred in a basis period that straddles two years of assessment, apportion the expenditure on a time basis. Provisional tax for the following year is computed on the estimated assessable profits after taking the super-deduction into account, subject to the holdover provisions.

Only one entity in a group of connected entities may elect the two-tiered profits tax rates. The super-deduction is available to all taxpayers, irrespective of whether they are taxed at the lower or upper rate, and does not affect the nomination of the connected entity for the two-tiered rates.

Economic Substance and Transfer Pricing Considerations

The super-deduction does not require a separate economic substance test. The IRD may review R&D claims as part of its broader compliance programme. A company claiming the super-deduction should be able to demonstrate that the R&D activities are genuine and that the expenditure is incurred for the purpose of producing assessable profits. This is consistent with the general requirement for deductible expenses to be incurred in the production of chargeable profits.

For multinational groups, the FSIE regime applies separately to foreign-sourced income received in Hong Kong. The super-deduction does not change the territorial source principle. The IRD may also review transfer pricing arrangements involving R&D expenditure, particularly where the taxpayer outsources R&D to a connected entity. Prepare transfer pricing documentation to support the arm's length nature of intra-group R&D service charges, ensuring compliance with the three-tier documentation rules where applicable.

Key Points for Taxpayers

• The super-deduction applies to qualifying R&D expenditure incurred in Hong Kong in a year of assessment.
• Type A expenditure (in-house R&D) qualifies for 200% deduction; Type B expenditure (outsourced R&D) for 300% deduction up to HK$3 million, then 200%.
• Capital expenditure on R&D assets does not qualify and is instead covered by depreciation allowances.
• The claim is made on the profits tax return using supplementary forms.
• Supporting documentation should be retained for IRD review.
• The deduction does not affect the territorial source principle or FSIE rules.
• Transfer pricing rules apply to cross-border R&D arrangements between connected entities.